These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 22204713)

  • 1. The Wnt/β-catenin pathway drives increased cyclin D1 levels in lymph node metastasis in papillary thyroid cancer.
    Zhang J; Gill AJ; Issacs JD; Atmore B; Johns A; Delbridge LW; Lai R; McMullen TP
    Hum Pathol; 2012 Jul; 43(7):1044-50. PubMed ID: 22204713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of CSN6 attenuates papillary thyroid carcinoma progression by reducing Wnt/β-catenin signaling and sensitizes cancer cells to FH535 therapy.
    Wen D; Liao T; Ma B; Qu N; Shi RL; Lu ZW; Wang YL; Wei WJ; Ji QH
    Cancer Med; 2018 Feb; 7(2):285-296. PubMed ID: 29341469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytosolic Cadherin 4 promotes angiogenesis and metastasis in papillary thyroid cancer by suppressing the ubiquitination/degradation of β-catenin.
    Wu L; Xiao J; Yi D; Ding H; Wang R; Duan Z; Liu Z; Shi X; Shen M; Sang J
    J Transl Med; 2024 Feb; 22(1):201. PubMed ID: 38402159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expression of c-MYC, Cyclin D1 and Ki-67/MIB-1 in benign and malignant thyroid tissues: is there any diagnostic value?
    Forozidou E; Syrnioti A; Laskou S; Poutoglidis A; Sapalidis K; Koletsa T
    Rom J Morphol Embryol; 2024; 65(2):267-271. PubMed ID: 39020541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dihydrotanshinone I exhibits antitumor effects via β-catenin downregulation in papillary thyroid cancer cell lines.
    Molteni E; Baldan F; Damante G; Allegri L
    Sci Rep; 2024 Apr; 14(1):7853. PubMed ID: 38570592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Complex Interplay between Notch Effectors and β-Catenin Signaling in Morular Differentiation of Endometrial Carcinoma Cells.
    Yokoi A; Murayama A; Hashimura M; Oguri Y; Harada Y; Fukagawa N; Hayashi M; Ono M; Ohhigata K; Saegusa M
    Am J Pathol; 2024 Mar; 194(3):459-470. PubMed ID: 38096983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and inactivation of glycogen synthase kinase 3 alpha/ beta and their association with the expression of cyclin D1 and p53 in oral squamous cell carcinoma progression.
    Mishra R; Nagini S; Rana A
    Mol Cancer; 2015 Feb; 14():20. PubMed ID: 25645517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bergapten attenuates human papillary thyroid cancer cell proliferation by triggering apoptosis and the GSK-3β, P13K and AKT pathways.
    Li J; Hussain SA; Daddam JR; Sun M
    Adv Clin Exp Med; 2024 Apr; ():. PubMed ID: 38591347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correction: Expression and inactivation of glycogen synthase kinase 3 alpha/ beta and their association with the expression of cyclin D1 and p53 in oral squamous cell carcinoma progression.
    Mishra R; Nagini S; Rana A
    Mol Cancer; 2024 Jul; 23(1):149. PubMed ID: 39054534
    [No Abstract]   [Full Text] [Related]  

  • 10. Erratum of "PLS3 promotes papillary thyroid carcinoma progression by activating the Notch signaling pathway".
    Environ Toxicol; 2024 Aug; 39(8):4261. PubMed ID: 38659362
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of cyclin D1 amplification and expression in vulvar carcinomas.
    Choschzick M; Hess S; Tennstedt P; Holst F; Bohlken H; Gieseking F; Mahner S; Woelber L; Simon R; Sauter G
    Hum Pathol; 2012 Sep; 43(9):1386-93. PubMed ID: 22406359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wnt/β-catenin signaling pathway upregulates c-Myc expression to promote cell proliferation of P19 teratocarcinoma cells.
    Zhang S; Li Y; Wu Y; Shi K; Bing L; Hao J
    Anat Rec (Hoboken); 2012 Dec; 295(12):2104-13. PubMed ID: 22976998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC.
    Morin PJ; Sparks AB; Korinek V; Barker N; Clevers H; Vogelstein B; Kinzler KW
    Science; 1997 Mar; 275(5307):1787-90. PubMed ID: 9065402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Removal of shelterin reveals the telomere end-protection problem.
    Sfeir A; de Lange T
    Science; 2012 May; 336(6081):593-7. PubMed ID: 22556254
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Piórkowska K; Zygmunt K; Hunter W; Wróblewska K
    Genes (Basel); 2024 Apr; 15(4):. PubMed ID: 38674413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Landscape of NcRNAs involved in drug resistance of breast cancer.
    Kang Y
    Clin Transl Oncol; 2023 Jul; 25(7):1869-1892. PubMed ID: 37067729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA LINC02613 is a prognostic biomarker for breast cancer and correlates with the cell cycle and immune infiltration based on TCGA data.
    Cui M; Liu Y; Cui L
    Transl Cancer Res; 2022 Apr; 11(4):615-628. PubMed ID: 35571659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased thyroid malignancy in patients with primary hyperparathyroidism.
    Li L; Li B; Lv B; Liang W; Zhang B; Zeng Q; Turner AG; Sheng L
    Endocr Connect; 2021 Aug; 10(8):885-893. PubMed ID: 34261038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA ABCC6P1 promotes proliferation and migration of papillary thyroid cancer cells via Wnt/β-catenin signaling pathway.
    Guan Y; Li Y; Yang QB; Yu J; Qiao H
    Ann Transl Med; 2021 Apr; 9(8):664. PubMed ID: 33987362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ellagic Acid Attenuates BLM-Induced Pulmonary Fibrosis via Inhibiting Wnt Signaling Pathway.
    Li X; Huang K; Liu X; Ruan H; Ma L; Liang J; Cui Y; Wang Y; Wu S; Li H; Wei Y; Li Z; Gao J; Yang B; Li X; Yang G; Zhou H; Yang C
    Front Pharmacol; 2021; 12():639574. PubMed ID: 33912053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.